People familiar with the business told the Journal that Kenvue plans to raise $3.5 billion and is meeting with potential investors on April 24.
Kenvue — which makes brands including Band-Aid, Tylenol, Neutrogena and Listerine — generated $14.95 billion in global sales for Johnson & Johnson in 2022.
The New Brunswick, N.J.-based drugmaker first announced the split into two independent companies in November 2021.
The Journal called the share sale the “biggest of what so far has been a quiet year for IPOs.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
